Impact of hepatitis C virus infection in renal allograft recipients

By Yacheng Y.   Zhilian M.   Yeuhua Z.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1949-1949

Elsevier

Access to resources Recommend Favorite

Individualization of maintenance immunosuppressive therapy equalizes acute rejection risk in African American versus non-African American renal allograft recipients

By Lewis R.   Coutee J.   Kostro B.   Calvert D.   Cava-Bartsch C.   Susskind B.   Swies G.   Burns T.  

Transplantation Proceedings, Vol. 33, Iss. 6, 2001-09 ,pp. : 2977-2979

Elsevier

Access to resources Recommend Favorite

Liver function tests in mycophenolate mofetil-treated hepatitis C virus-positive kidney allograft recipients

By Ribeiro A.R.   Veronese F.V.   Manfro R.C.   Goncalves L.F.  

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 489-490

Elsevier

Access to resources Recommend Favorite

Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection

By Burke G.W.   Ciancio C.   Blomberg B.B.   Rosen A.   Suzart K.   Roth D.   Kupin W.   Esquenazi V.   Miller J.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1610-1611

Elsevier

Access to resources Recommend Favorite

Lamivudine therapy in renal allograft recipients with hepatitis B virus infection

By Tsang W.K.   Tong K.L.   Chan H.W.H.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 278-279

Elsevier

Access to resources Recommend Favorite